Ventyx Biosciences (VTYX)
(Delayed Data from NSDQ)
$2.53 USD
-0.05 (-1.94%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $2.52 -0.01 (-0.40%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Ventyx Biosciences, Inc. has a market cap of $183.60M, which represents its share price of $2.58 multiplied by its outstanding shares number of 71.16M. As a small-cap company, VTYX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
VTYX 2.53 -0.05(-1.94%)
Will VTYX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for VTYX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VTYX
Ventyx Biosciences (VTYX) Upgraded to Strong Buy: What Does It Mean for the Stock?
VTYX Stock Rises on Strategic Equity Investment Deal With SNY
VTYX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for VTYX
Commit To Buy Ventyx Biosciences At $2.50, Earn 56.9% Annualized Using Options
Analysts Are Bullish on Top Healthcare Stocks: Eli Lilly & Co (LLY), Ventyx Biosciences (VTYX)
Oppenheimer Reaffirms Their Buy Rating on Ventyx Biosciences (VTYX)
Hold Rating for Ventyx Biosciences Amid Promising Early Data and Strategic Uncertainties
Positive Outlook on Ventyx Biosciences Due to Promising Developments in Neuro-Inflammatory Treatments